Nodular Regenerative Hyperplasia After Treatment With Trastuzumab Emtansine

J Clin Oncol. 2016 Jan 20;34(3):e9-12. doi: 10.1200/JCO.2013.49.8543. Epub 2014 Apr 28.

Authors

Jeremy Force¹, Romil Saxena¹, Bryan P Schneider¹, Anna M Storniolo¹, George W Sledge Jr¹, Naga Chalasani¹, Raj Vuppalanchi²

Affiliations

¹ Indiana University School of Medicine, Indiana University Health, Indianapolis, IN.
² Indiana University School of Medicine, Indiana University Health, Indianapolis, IN rvuppala@iupui.edu.

PMID: 24778392
DOI: 10.1200/JCO.2013.49.8543

No abstract available

Publication types

Case Reports

MeSH terms

Ado-Trastuzumab Emtansine
Aged
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Breast Neoplasms / drug therapy
Carcinoma, Ductal, Breast / drug therapy
Female
Humans
Hyperplasia / chemically induced
Hypertension, Portal / chemically induced*
Hypertension, Portal / pathology*
Liver / drug effects*
Liver / pathology*
Maytansine / adverse effects
Maytansine / analogs & derivatives*
Maytansine / therapeutic use
Middle Aged
Trastuzumab

Substances

Antibodies, Monoclonal, Humanized
Maytansine
Trastuzumab
Ado-Trastuzumab Emtansine